James Yang, Director of the Department of Oncology at National Taiwan University Hospital and Director of the Graduate Institute of Oncology at National Taiwan University, discusses the important role of oncology research in developing the Taiwanese pharmaceutical market as well as the new National Taiwanese University Cancer Center (which will provide care for 500 beds as well as tremendously increase the oncology research capacity in Taiwan in particular and in Asia in general).
You were appointed Director of the Department of Oncology of the National Taiwan University Hospital in August 2015. You also participated in the establishment of the new National Taiwan University Cancer Center. Can you tell us more about this center?
"We see ourselves as experimental therapists and while we offer standard care to our patients, we also want to offer them the opportunity to access the most pioneering treatment alternatives."
